The DECLARATION (safety and efficacy vs. placebo) and LIBERTY (exploratory safety head-to-head and combination with mRNA-based COVID vaccination) clinical trials are expected to begin around year-end 2025; top-line data anticipated mid-2026DECLARATION is a Phase 3, randomized, placebo-controlled clinical trial to evaluate prevention of COVID, at three months, from a single intramuscular (IM) dose of VYD2311, with longer-term protection anticipated. A second VYD2311 arm will evaluate monthly IM doses to demo ...

华夏时报记者于玉金北京报道 在《志愿军：浴血和平》(下称"《志愿军3》")《731》影片的带动下，国庆档票房成绩一路攀升。根据灯塔专业版数据，截至10月5日17时16分，2025年 国庆档票房(含预售)突破13亿元。《志愿军3》《731》《刺杀小说家2》《浪浪人生》《震耳欲聋》暂列票房前五名，且各片档期票房均突破1亿元。 中国青年剧作家、导演向凯在接受《华夏时报》采访时表示，今年国庆档电影题材虽丰富多元，但单片票房表现并不十分理想。不过，由于今年档期比去 年多出一天，整体票房成绩预计将与去年持平。他指出，电影《震耳欲聋》将在档期后半段成为支撑票房的重要力量。 此外，犯罪剧情片《毕正明的证明》凭借优异口碑，率先实现单日票房逆跌，并已连续两天保持这一趋势，预计仍有望在长尾阶段收获良好票房表现。 追赶去年档期成绩 今年国庆档影片类型丰富多元，涵盖历史战争、奇幻动作、喜剧家庭、动画以及犯罪剧情等多种题材，满足了成人、家庭及儿童等不同观众群体的观影需 求。 如档期前的预测，《志愿军3》在今年的国庆档领跑。截至10月5日21时，该片票房为3.79亿元。 灯塔专业版数据分析师陈晋告诉本报记者，《志愿军3》持续领跑国庆档票房 ...

NEW YORK, NY / ACCESS Newswire / October 6, 2025 / California never misses a chance to make a statement or a lawsuit. So when Los Angeles County went after Coca-Cola and PepsiCo for allegedly misleading consumers about plastic waste, the headlines practically wrote themselves. ...

Burixafor (GPC-100) Phase 2 Trial in Multiple Myeloma Nears Key Readout Preparing for Expansion into Sickle Cell Disease and Acute Myeloid Leukemia New Leadership Appointments Bring Deep Drug Development Expertise REDWOOD CITY, Calif., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Exicure, Inc. (Nasdaq: XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today shared recent progress for its lead program, burixafor (GPC-100), outlined upcoming strategic priorities, and introdu ...

With 16,000+ economy independent hotels in the U.S. alone, Wyndham's newest offering fills a long- overlooked gap in the soft-brand landscape , /PRNewswire/ -- Wyndham Hotels & Resorts, the world's largest hotel franchising company, today launched Dazzler Select by Wyndham, a new franchise offering designed for independent hoteliers in the economy lifestyle space. Wyndham today introduced Dazzler Select by Wyndham, an extension of its boutique-inspired Dazzler by Wyndham brand, designed for independent hote ...

Preliminary unaudited results indicate record quarterly and annual revenue, beating internal guidance by over 5% and representing approximately 43% annual growth Deliveries in the quarter included core material handling battery system products in addition to initial deliveries of robotic battery products TORONTO, ON / ACCESS Newswire / October 6, 2025 / Electrovaya Inc. ("Electrovaya" or the "Company") (Nasdaq:ELVA)(TSX:ELVA), a lithium-ion battery technology and manufacturing company, today announced its p ...

Toronto, Ontario--(Newsfile Corp. - October 6, 2025) - 'Inside the Boardroom' is more than just an interview series - it's a chance to gain firsthand knowledge from industry leaders, understanding their vision, challenges, and strategy.Meet the Executive Shaping the Tech LandscapeWe caught up with Evan Gappelberg, CEO of Nextech3D.ai (OTCQB: NEXCF) (CSE: NTAR) (FSE: 1SS). Follow what investors are saying and join our community: https://ceo.ca/ntarNextech3D.AI(OTCQB: NEXCF) (CSE: NTAR) (FSE: 1SS)Cannot view ...

, /PRNewswire/ -- Ceragon (NASDAQ: CRNT), a leading solutions provider of end-to-end wireless connectivity, will showcase its latest breakthroughs at India Mobile Congress (IMC) 2025, taking place October 8–11 in New Delhi. Visitors can experience exclusive live demos and explore solutions designed to meet the most complex network demands at Booth A10. Key demonstrations will include: In addition to live demos, Ceragon executives will bring their insights to the following IMC panels: "IMC is the perfect st ...

Presenter: Dr. Manish Sharma, MD, Co-Director of Clinical Research, START Midwest, Grand Rapids Date: Friday, November 7, 2025 About Compugen Compugen is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive AI/ML powered computational discovery platform (Unigen) to identify new drug targets and biological pathways for developing cancer immunotherapies. Compugen has two proprietary product candidates in Phase 1 development: COM701, a potential first-in- ...

MIAMI BEACH, FL / ACCESS Newswire / October 6, 2025 / C2 Blockchain Inc. (OTCID:CBLO), a blockchain infrastructure and digital asset company, today announced that its corporate DOG Coin treasury has increased from 507,668,698 DOG to 513,405,065 DOG, marking the acquisition of an additional 5,736,367 DOG coins as part of the company's ongoing digital asset accumulation strategy. This expansion reinforces C2 Blockchain's long-term commitment to establishing DOG Coin - the first meme coin natively built on the ...